The human immunodeficiency virus (HIV) Rev-binding protein (HRB) is a co-factor for HIV-1 Nef-mediated CD4 downregulation. 2016

Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
Department of Clinical Chemistry, Microbiology, and Immunology, Ghent University, Ghent, Belgium.

Human immunodeficiency virus type 1 (HIV-1)-mediated CD4 downregulation is an important determinant of viral replication in vivo. Research on cellular co-factors involved in this process could lead to the identification of potential therapeutic targets. We found that CD4 surface levels were significantly higher in HIV-1-infected cells knocked-down for the HIV Rev-binding protein (HRB) compared with control cells. HRB knock-down affected CD4 downregulation induced by Nef but not by HIV-1 Vpu. Interestingly, the knock-down of the related protein HRBL (HRB-like), but not of the HRB interaction partner EPS15 (epidermal growth factor receptor pathway substrate 15), increased CD4 levels in Vpu-expressing cells significantly. Both of these proteins are known to be involved in HIV-1-mediated CD4 downregulation as co-factors of HIV-1 Nef. These results identify HRB as a previously unknown co-factor for HIV-1 Nef-mediated CD4 downregulation and highlight differences with the related protein HRBL, which affects the CD4 downregulation in a dual role as co-factor of both HIV-1 Nef and Vpu.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015704 CD4 Antigens 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120. Antigens, CD4,CD4 Molecule,CD4 Receptor,CD4 Receptors,Receptors, CD4,T4 Antigens, T-Cell,CD4 Antigen,Receptors, Surface CD4,Surface CD4 Receptor,Antigen, CD4,Antigens, T-Cell T4,CD4 Receptor, Surface,CD4 Receptors, Surface,Receptor, CD4,Surface CD4 Receptors,T-Cell T4 Antigens,T4 Antigens, T Cell
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein
D054298 Human Immunodeficiency Virus Proteins Proteins synthesized by HUMAN IMMUNODEFICIENCY VIRUSES such as the HIV-1 and HIV-2. HIV Proteins,HIV Gene Products,Human Immunodeficiency Virus Gene Products
D054311 nef Gene Products, Human Immunodeficiency Virus Proteins encoded by the NEF GENES of the HUMAN IMMUNODEFICIENCY VIRUS. nef Protein, Human Immunodeficiency Virus,HIV-3'-orf Protein,nef Protein, HIV,HIV 3' orf Protein,HIV nef Protein
D054321 rev Gene Products, Human Immunodeficiency Virus Proteins encoded by the REV GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV rev Gene Product,Trans-Activator Protein, HIV,art-trs Gene Protein, HIV,trs-art Gene Protein, HIV,HIV art-trs Gene Protein,HIV trs-art Gene Protein,Transactivator Protein, HIV,HIV Trans-Activator Protein,HIV Transactivator Protein,HIV art trs Gene Protein,HIV trs art Gene Protein,Trans Activator Protein, HIV,art trs Gene Protein, HIV,trs art Gene Protein, HIV
D054334 Viral Regulatory and Accessory Proteins A broad category of viral proteins that play indirect roles in the biological processes and activities of viruses. Included here are proteins that either regulate the expression of viral genes or are involved in modifying host cell functions. Many of the proteins in this category serve multiple functions. Viral Accessory Proteins,Viral Regulatory Proteins,Regulatory Proteins, Viral,Accessory Proteins, Viral,Proteins, Viral Accessory,Proteins, Viral Regulatory

Related Publications

Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
February 2003, Journal of virology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
February 1997, Genomics,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
March 2001, Journal of virology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
May 2002, Journal of virology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
February 1995, Virology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
September 1996, FEBS letters,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
October 1996, Journal of molecular biology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
April 2001, Journal of virology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
September 1994, Journal of virology,
Alessia Landi, and Cristina Garcia Timermans, and Evelien Naessens, and Hanne Vanderstraeten, and Veronique Stove, and Bruno Verhasselt
November 2009, Journal of molecular biology,
Copied contents to your clipboard!